Matthew J. Mitcheltree

Statistics

Publications

Citations

408

H-Index

Active since

2020

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Harvard University

University of Illinois Chicago

Matthew J. Mitcheltree is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, drug discovery, and pharmacy.

ORCID

Publications per year

2020–2024

Publications

A synthetic antibiotic class overcoming bacterial multidrug resistance

Matthew J. Mitcheltree, Amarnath Pisipati, Egor A. Syroegin et al. · Nature · 2021 · 232 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +14

An antibiotic preorganized for ribosomal binding overcomes antimicrobial resistance

Kelvin J. Y. Wu, Ben I. C. Tresco, Antonio Ramkissoon et al. · Science · 2024 · 73 citations · Full text

Life Sciences, Medicinal Chemistry, Microbiology +17

Bioisostere Effects on the EPSA of Common Permeability-Limiting Groups

Andrew K. Ecker, Dorothy Levorse, Daniel A. Victor et al. · ACS Medicinal Chemistry Letters · 2022 · 31 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +13

Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy

Matthew J. Mitcheltree, Derun Li, Abdelghani Achab et al. · ACS Medicinal Chemistry Letters · 2020 · 30 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

A Practical, Component-Based Synthetic Route to Methylthiolincosamine Permitting Facile Northern-Half Diversification of Lincosamide Antibiotics

Matthew J. Mitcheltree, Jack W. Stevenson, Amarnath Pisipati et al. · Journal of the American Chemical Society · 2021 · 21 citations

Pharmacy, Chemistry, Medicinal Chemistry +16

1–5 of 6